The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Novel Vaccine Delivery Systems Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Novel Vaccine Delivery Systems Market
Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.
The global Novel Vaccine Delivery Systems market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Intramuscular Delivery accounting for % of the Novel Vaccine Delivery Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals & Clinics segment is altered to an % CAGR throughout this forecast period.
China Novel Vaccine Delivery Systems market size is valued at US$ million in 2021, while the North America and Europe Novel Vaccine Delivery Systems are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Novel Vaccine Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Novel Vaccine Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Novel Vaccine Delivery Systems market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Novel Vaccine Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Novel Vaccine Delivery Systems market.
Global Novel Vaccine Delivery Systems Scope and Market Size
Novel Vaccine Delivery Systems market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Novel Vaccine Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Intramuscular Delivery
Intramuscular Delivery
Others
Segment by Application
Hospitals & Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Altaris Capital Partners
Kindeva Drug Delivery
Becton
Dickinson,
Carl Zeiss Foundation
Gerresheimer AG
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
VAXXAS
Market Analysis and Insights: Global Novel Vaccine Delivery Systems Market
Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.
The global Novel Vaccine Delivery Systems market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Intramuscular Delivery accounting for % of the Novel Vaccine Delivery Systems global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals & Clinics segment is altered to an % CAGR throughout this forecast period.
China Novel Vaccine Delivery Systems market size is valued at US$ million in 2021, while the North America and Europe Novel Vaccine Delivery Systems are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Novel Vaccine Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Novel Vaccine Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Novel Vaccine Delivery Systems market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Novel Vaccine Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Novel Vaccine Delivery Systems market.
Global Novel Vaccine Delivery Systems Scope and Market Size
Novel Vaccine Delivery Systems market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Novel Vaccine Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Intramuscular Delivery
Intramuscular Delivery
Others
Segment by Application
Hospitals & Clinics
Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Altaris Capital Partners
Kindeva Drug Delivery
Becton
Dickinson,
Carl Zeiss Foundation
Gerresheimer AG
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
VAXXAS
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Intramuscular Delivery
1.2.3 Intramuscular Delivery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Novel Vaccine Delivery Systems Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals & Clinics
1.3.3 Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Novel Vaccine Delivery Systems Market Perspective (2017-2028)
2.2 Novel Vaccine Delivery Systems Growth Trends by Region
2.2.1 Novel Vaccine Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Novel Vaccine Delivery Systems Historic Market Size by Region (2017-2022)
2.2.3 Novel Vaccine Delivery Systems Forecasted Market Size by Region (2023-2028)
2.3 Novel Vaccine Delivery Systems Market Dynamics
2.3.1 Novel Vaccine Delivery Systems Industry Trends
2.3.2 Novel Vaccine Delivery Systems Market Drivers
2.3.3 Novel Vaccine Delivery Systems Market Challenges
2.3.4 Novel Vaccine Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Vaccine Delivery Systems Players by Revenue
3.1.1 Global Top Novel Vaccine Delivery Systems Players by Revenue (2017-2022)
3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2017-2022)
3.2 Global Novel Vaccine Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Vaccine Delivery Systems Revenue
3.4 Global Novel Vaccine Delivery Systems Market Concentration Ratio
3.4.1 Global Novel Vaccine Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Vaccine Delivery Systems Revenue in 2021
3.5 Novel Vaccine Delivery Systems Key Players Head office and Area Served
3.6 Key Players Novel Vaccine Delivery Systems Product Solution and Service
3.7 Date of Enter into Novel Vaccine Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Vaccine Delivery Systems Breakdown Data by Type
4.1 Global Novel Vaccine Delivery Systems Historic Market Size by Type (2017-2022)
4.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2023-2028)
5 Novel Vaccine Delivery Systems Breakdown Data by Application
5.1 Global Novel Vaccine Delivery Systems Historic Market Size by Application (2017-2022)
5.2 Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Novel Vaccine Delivery Systems Market Size (2017-2028)
6.2 North America Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
6.3 North America Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Novel Vaccine Delivery Systems Market Size (2017-2028)
7.2 Europe Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
7.3 Europe Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Vaccine Delivery Systems Market Size (2017-2028)
8.2 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
8.3 Asia-Pacific Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Novel Vaccine Delivery Systems Market Size (2017-2028)
9.2 Latin America Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
9.3 Latin America Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Vaccine Delivery Systems Market Size (2017-2028)
10.2 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
10.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Altaris Capital Partners
11.1.1 Altaris Capital Partners Company Detail
11.1.2 Altaris Capital Partners Business Overview
11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Introduction
11.1.4 Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.1.5 Altaris Capital Partners Recent Development
11.2 Kindeva Drug Delivery
11.2.1 Kindeva Drug Delivery Company Detail
11.2.2 Kindeva Drug Delivery Business Overview
11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Introduction
11.2.4 Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.2.5 Kindeva Drug Delivery Recent Development
11.3 Becton
11.3.1 Becton Company Detail
11.3.2 Becton Business Overview
11.3.3 Becton Novel Vaccine Delivery Systems Introduction
11.3.4 Becton Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.3.5 Becton Recent Development
11.4 Dickinson,
11.4.1 Dickinson, Company Detail
11.4.2 Dickinson, Business Overview
11.4.3 Dickinson, Novel Vaccine Delivery Systems Introduction
11.4.4 Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.4.5 Dickinson, Recent Development
11.5 Carl Zeiss Foundation
11.5.1 Carl Zeiss Foundation Company Detail
11.5.2 Carl Zeiss Foundation Business Overview
11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Introduction
11.5.4 Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.5.5 Carl Zeiss Foundation Recent Development
11.6 Gerresheimer AG
11.6.1 Gerresheimer AG Company Detail
11.6.2 Gerresheimer AG Business Overview
11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Introduction
11.6.4 Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.6.5 Gerresheimer AG Recent Development
11.7 Corium International
11.7.1 Corium International Company Detail
11.7.2 Corium International Business Overview
11.7.3 Corium International Novel Vaccine Delivery Systems Introduction
11.7.4 Corium International Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.7.5 Corium International Recent Development
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Detail
11.8.2 Inovio Pharmaceuticals Business Overview
11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Introduction
11.8.4 Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.8.5 Inovio Pharmaceuticals Recent Development
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Detail
11.9.2 Bioject Medical Technologies Business Overview
11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Introduction
11.9.4 Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.9.5 Bioject Medical Technologies Recent Development
11.10 PharmaJet
11.10.1 PharmaJet Company Detail
11.10.2 PharmaJet Business Overview
11.10.3 PharmaJet Novel Vaccine Delivery Systems Introduction
11.10.4 PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.10.5 PharmaJet Recent Development
11.11 Retractable Technologies
11.11.1 Retractable Technologies Company Detail
11.11.2 Retractable Technologies Business Overview
11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Introduction
11.11.4 Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.11.5 Retractable Technologies Recent Development
11.12 Terumo Corporation
11.12.1 Terumo Corporation Company Detail
11.12.2 Terumo Corporation Business Overview
11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Introduction
11.12.4 Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.12.5 Terumo Corporation Recent Development
11.13 VAXXAS
11.13.1 VAXXAS Company Detail
11.13.2 VAXXAS Business Overview
11.13.3 VAXXAS Novel Vaccine Delivery Systems Introduction
11.13.4 VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2017-2022)
11.13.5 VAXXAS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Novel Vaccine Delivery Systems Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Intramuscular Delivery
Table 3. Key Players of Intramuscular Delivery
Table 4. Key Players of Others
Table 5. Global Novel Vaccine Delivery Systems Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Novel Vaccine Delivery Systems Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Novel Vaccine Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Novel Vaccine Delivery Systems Market Share by Region (2017-2022)
Table 9. Global Novel Vaccine Delivery Systems Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Novel Vaccine Delivery Systems Market Share by Region (2023-2028)
Table 11. Novel Vaccine Delivery Systems Market Trends
Table 12. Novel Vaccine Delivery Systems Market Drivers
Table 13. Novel Vaccine Delivery Systems Market Challenges
Table 14. Novel Vaccine Delivery Systems Market Restraints
Table 15. Global Novel Vaccine Delivery Systems Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Novel Vaccine Delivery Systems Market Share by Players (2017-2022)
Table 17. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2021)
Table 18. Ranking of Global Top Novel Vaccine Delivery Systems Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Novel Vaccine Delivery Systems Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Novel Vaccine Delivery Systems Product Solution and Service
Table 22. Date of Enter into Novel Vaccine Delivery Systems Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Novel Vaccine Delivery Systems Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2017-2022)
Table 26. Global Novel Vaccine Delivery Systems Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Novel Vaccine Delivery Systems Revenue Market Share by Type (2023-2028)
Table 28. Global Novel Vaccine Delivery Systems Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2017-2022)
Table 30. Global Novel Vaccine Delivery Systems Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Novel Vaccine Delivery Systems Revenue Market Share by Application (2023-2028)
Table 32. North America Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Novel Vaccine Delivery Systems Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Country (2023-2028) & (US$ Million)
Table 42. Altaris Capital Partners Company Detail
Table 43. Altaris Capital Partners Business Overview
Table 44. Altaris Capital Partners Novel Vaccine Delivery Systems Product
Table 45. Altaris Capital Partners Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 46. Altaris Capital Partners Recent Development
Table 47. Kindeva Drug Delivery Company Detail
Table 48. Kindeva Drug Delivery Business Overview
Table 49. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product
Table 50. Kindeva Drug Delivery Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 51. Kindeva Drug Delivery Recent Development
Table 52. Becton Company Detail
Table 53. Becton Business Overview
Table 54. Becton Novel Vaccine Delivery Systems Product
Table 55. Becton Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 56. Becton Recent Development
Table 57. Dickinson, Company Detail
Table 58. Dickinson, Business Overview
Table 59. Dickinson, Novel Vaccine Delivery Systems Product
Table 60. Dickinson, Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 61. Dickinson, Recent Development
Table 62. Carl Zeiss Foundation Company Detail
Table 63. Carl Zeiss Foundation Business Overview
Table 64. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product
Table 65. Carl Zeiss Foundation Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 66. Carl Zeiss Foundation Recent Development
Table 67. Gerresheimer AG Company Detail
Table 68. Gerresheimer AG Business Overview
Table 69. Gerresheimer AG Novel Vaccine Delivery Systems Product
Table 70. Gerresheimer AG Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 71. Gerresheimer AG Recent Development
Table 72. Corium International Company Detail
Table 73. Corium International Business Overview
Table 74. Corium International Novel Vaccine Delivery Systems Product
Table 75. Corium International Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 76. Corium International Recent Development
Table 77. Inovio Pharmaceuticals Company Detail
Table 78. Inovio Pharmaceuticals Business Overview
Table 79. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product
Table 80. Inovio Pharmaceuticals Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 81. Inovio Pharmaceuticals Recent Development
Table 82. Bioject Medical Technologies Company Detail
Table 83. Bioject Medical Technologies Business Overview
Table 84. Bioject Medical Technologies Novel Vaccine Delivery Systems Product
Table 85. Bioject Medical Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 86. Bioject Medical Technologies Recent Development
Table 87. PharmaJet Company Detail
Table 88. PharmaJet Business Overview
Table 89. PharmaJet Novel Vaccine Delivery Systems Product
Table 90. PharmaJet Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 91. PharmaJet Recent Development
Table 92. Retractable Technologies Company Detail
Table 93. Retractable Technologies Business Overview
Table 94. Retractable Technologies Novel Vaccine Delivery SystemsProduct
Table 95. Retractable Technologies Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 96. Retractable Technologies Recent Development
Table 97. Terumo Corporation Company Detail
Table 98. Terumo Corporation Business Overview
Table 99. Terumo Corporation Novel Vaccine Delivery SystemsProduct
Table 100. Terumo Corporation Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 101. Terumo Corporation Recent Development
Table 102. VAXXAS Company Detail
Table 103. VAXXAS Business Overview
Table 104. VAXXAS Novel Vaccine Delivery SystemsProduct
Table 105. VAXXAS Revenue in Novel Vaccine Delivery Systems Business (2017-2022) & (US$ Million)
Table 106. VAXXAS Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Vaccine Delivery Systems Market Share by Type: 2021 VS 2028
Figure 2. Intramuscular Delivery Features
Figure 3. Intramuscular Delivery Features
Figure 4. Others Features
Figure 5. Global Novel Vaccine Delivery Systems Market Share by Application in 2021 & 2028
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Novel Vaccine Delivery Systems Report Years Considered
Figure 10. Global Novel Vaccine Delivery Systems Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Novel Vaccine Delivery Systems Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Novel Vaccine Delivery Systems Market Share by Region: 2021 VS 2028
Figure 13. Global Novel Vaccine Delivery Systems Market Share by Players in 2021
Figure 14. Global Top Novel Vaccine Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Vaccine Delivery Systems as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Novel Vaccine Delivery Systems Revenue in 2021
Figure 16. North America Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
Figure 18. United States Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
Figure 22. Germany Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Novel Vaccine Delivery Systems Market Share by Region (2017-2028)
Figure 30. China Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
Figure 38. Mexico Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Novel Vaccine Delivery Systems Market Share by Country (2017-2028)
Figure 42. Turkey Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Novel Vaccine Delivery Systems Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Altaris Capital Partners Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 45. Kindeva Drug Delivery Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 46. Becton Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 47. Dickinson, Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 48. Carl Zeiss Foundation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 49. Gerresheimer AG Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 50. Corium International Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 51. Inovio Pharmaceuticals Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 52. Bioject Medical Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 53. PharmaJet Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 54. Retractable Technologies Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 55. Terumo Corporation Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 56. VAXXAS Revenue Growth Rate in Novel Vaccine Delivery Systems Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
